Paul Jansen

Paul Jansen has a strong drug/ biologics device development experience, including registration, CMC, manufacturing, quality, business development. Prior to becoming a board member at the Haselmeier Group, Paul spent a combined 25 years at Eli Lilly and Sanofi, where he oversaw the development of medical devices. He has demonstrated success in cross-cultural work environments (Japan and EU) and has excellent project management skills. Paul has a demonstrated ability to think strategically, creatively and tactically ensuring that thoughtful plans translate into coordinated action.